| Segment Reporting |
The following table contains additional information on the Company’s consolidated revenue and net loss, including significant segment expenses (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | | 2025 | | 2026 | | | 2025 | | Collaboration and other research and development revenues | $ | 11,890 | | | | $ | 3,578 | | | $ | 14,721 | | | | $ | 8,236 | | | Operating expenses: | | | | | | | | | | Research and development1 | | | | | | | | | | | Employee related expenses | 4,900 | | | | 8,575 | | | 10,320 | | | | 22,742 | | | External research and development expenses | 5,851 | | | | 25,111 | | | 9,355 | | | | 60,466 | | | Facility expenses | 3,287 | | | | 4,581 | | | 6,512 | | | | 13,974 | | | Stock-based compensation expenses | 644 | | | | 863 | | | 1,187 | | | | 1,770 | | | Sublicense and license fees | 1,643 | | | | 95 | | | 4,054 | | | | 112 | | Other expenses3 | 2,516 | | | | 1,787 | | | 5,013 | | | | 7,785 | | General and administrative2 | | | | | | | | | | | Employee related expenses | 1,972 | | | | 3,436 | | | 4,081 | | | | 8,541 | | | Professional service expenses | 1,838 | | | | 3,711 | | | 3,728 | | | | 6,151 | | | Intellectual property and patent related fees | 4,557 | | | | 3,221 | | | 7,659 | | | | 5,767 | | | Stock-based compensation expenses | 1,549 | | | | 1,801 | | | 3,108 | | | | 3,873 | | Facility and other expenses4 | 1,687 | | | | 1,941 | | | 3,261 | | | | 4,762 | | | Total operating expenses | 30,444 | | | | 55,122 | | | 58,278 | | | | 135,943 | | | | | | | | | | | | | | | | | | | | | | | Interest expense related to sale of future revenues | (1,061) | | | | (2,020) | | | (2,133) | | | | (4,236) | | | Interest income, net | 1,368 | | | | 2,087 | | | 2,574 | | | | 4,803 | | | Other income (expense), net | 17 | | | | (1,758) | | | (96) | | | | (2,183) | | | Total other income (expense), net | 324 | | | | (1,691) | | | 345 | | | | (1,616) | | | Net loss | $ | (18,230) | | | | $ | (53,235) | | | $ | (43,212) | | | | $ | (129,323) | | | | | | | | | | | | 1 For the three and six months ended June 30, 2026, research and development includes $1.3 million of benefit within restructuring and impairment charges. For the three and six months ended June 30, 2025, research and development includes $24.8 million and $64.1 million of restructuring and impairment charges, respectively. | 2 For the three and six months ended June 30, 2026, general and administrative includes no restructuring and impairment charges. For the three and six months ended June 30, 2025, general and administrative includes $1.3 million and $2.9 million of restructuring and impairment charges, respectively. | 3 Other expenses primarily consists of impairment charges, consultant fees, and office expenses. | 4 Facility and other expenses primarily consists of rent expense, insurance premiums, depreciation expense, software licenses, and office expenses. |
|